Brean Murray Carret & Co. Starts Abbott Labs (ABT) at Hold; Tougher 2012-13 on the Horizon& Visibility Not Great
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $110.66 -0.53%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Brean Murray Carret & Co. initiates coverage on Abbott Labs (NYSE: ABT) with a Hold.
Brean analyst says, "The current valuation does reflect an anticipated slowdown, however, and potentially set up an attractive risk/reward should our conviction in new growth opportunities increase."
For more ratings news on Abbott Labs click here and for the rating history of Abbott Labs click here.
Shares of Abbott Labs closed at $51.29 yesterday.
Brean analyst says, "The current valuation does reflect an anticipated slowdown, however, and potentially set up an attractive risk/reward should our conviction in new growth opportunities increase."
For more ratings news on Abbott Labs click here and for the rating history of Abbott Labs click here.
Shares of Abbott Labs closed at $51.29 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
- Jefferies Assumes Honeywell International (HON) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
